share_log

Today's Analyst Rating | Deutsche Bank Upgrades Boston Scientific to Buy, Morgan Stanley Upgrades Gilead Sciences to Buy

Moomoo News ·  Jan 10 21:00  · Ratings

Jan 10, Wall Street analysts have updated their stock ratings today including $Boston Scientific (BSX.US)$ and $Gilead Sciences (GILD.US)$.

Upgrades:

Deutsche Bank analyst Pito Chickering upgrades $Boston Scientific (BSX.US)$ to buy rating, and adjust the target price from USD78 to USD108.

Morgan Stanley analyst Terence Flynn upgrades $Gilead Sciences (GILD.US)$ to buy rating, and adjust the target price from USD79 to USD113.

Piper Sandler analyst Anna Andreeva upgrades $Nike (NKE.US)$ to buy rating, and adjust the target price from USD80 to USD90.

Downgrades:

Wells Fargo analyst Mohit Bansal maintains $Regeneron Pharmaceuticals (REGN.US)$ with buy rating, and adjust the target price from USD1050 to USD900.

Wells Fargo analyst Ike Boruchow downgrades $Ross Stores (ROST.US)$ to hold rating, and maintains the target price of USD165.

For more trending U.S. stock ratings today, refer to the chart below:

USTodayAnalystRatingAutoNewsSpider_mm_20250110_1736514001_en-us

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment